Wegovy is the first-and-only medication indicated for both chronic weight management and to reduce the risk of non-fatal myocardial infarction (MI) in Canada
HaVy Ngo-Hamilton, pharmacist and clinical consultant for BuzzRx, explains what this means: While both semaglutide and tirzepatide are administered by injection, they have different dosage schedules, rates of occurrence for potential side effects and costs, she explains
Nausea is the most common tirzepatide side effect (2540% of users in early weeks)
For an accurate estimate of your out-of-pocket costs, its best to check with your pharmacy and insurance provider
We work with pharmacy partners to monitor product availability, shipping timelines, and quality standards
Su tecnologa avanzada combate la flacidez y renueva cada capa de tu piel